Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Risk crawled date : 2021 - 05 - 11 save search
Efficacy Of Repatha® (Evolocumab) Across High-Risk Patient Populations Reinforced At ACC.21
Published: 2021-05-11 (Crawled : 20:00) - biospace.com/
BGNE | $129.995 -1.49% 110K
|
Health Technology
|
| O: -1.96%
H: 8.74%
C: 8.28%
AMGN | $267.41 1.77% 1.4M
|
Health Technology
|
| O: 0.21%
H: 1.11%
C: -0.34%
risk
New Study Predicts Risks of Drug Interactions without Exposing Patients to Harm
Published: 2021-05-11 (Crawled : 15:00) - tabularasahealthcare.com
TRHC | $10.5 -0.1% 1.3M
|
Technology Services
|
| O: -2.43%
H: 1.65%
C: -0.85%
risk drug
The Open Visibility Network welcomes Everstream Analytics - adds risk analytics to the shipping industry visibility data sharing network
Published: 2021-05-11 (Crawled : 15:00) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -6.43%
H: 6.71%
C: 5.32%
risk analytics
New National Eye Institute Data Shows AREDS2 Nutrient Formula Continues To Reduce The Risk Of Moderate To Advanced Age-Related Macular Degeneration Progression
Published: 2021-05-11 (Crawled : 12:00) - biospace.com/
BHC | $8.63 0.35% 2.1M
|
Health Technology
|
| O: -2.69%
H: 3.55%
C: 2.39%
eye risk macular
Gainers vs Losers
| 71% | 29% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.0503 39.72% 320M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
NVFY | $2.65 25.59% 33M
|
Consumer Durables
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.